Psychedelic Stocks Soar as Trump Signs Order to Ease Access
Shares of companies involved in psychedelic-related therapies are surging in premarket trading Monday after President Donald Trump signed an executive order to expedite research and access.
By Angel Adegbesan · Bloomberg Markets
Shares of companies involved in psychedelic-related therapies are surging in premarket trading Monday after President Donald Trump signed an executive order to expedite research and access.